Table 1.
Baseline characteristics of the study population.
Table 2.
Clinical parameters associated with baseline Gal-3 plasma levels in study population.
Fig 1.
Gal-3 plasma levels in patients with AF and AF-free cohort.
Table 3.
Clinical parameters associated with baseline Gal-3 plasma levels in AF patients.
Fig 2.
Gal-3 plasma levels in cardiac and peripheral circulation.
Table 4.
Clinical characteristics and Gal-3 plasma levels at baseline and 6 months after catheter ablation in patients with and without AF recurrences.
Fig 3.
Gal-3 plasma levels in AF patients with and without AF recurrences.